DOI:
10.1055/s-00029025
Journal of Pediatric Epilepsy
LinksClose Window
References
BRIM-P.
A study of vemurafenib in pediatric patients with stage IIIC or stage IV melanoma harboring BRAFV600 mutations.
Available at:
https://www.clinicaltrials.gov/ct2/show/NCT01519323
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.